CliffBio
small molecule

BEKYREE

DESOGESTREL; ETHINYL ESTRADIOL

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameBEKYREE
Active ingredientDESOGESTREL; ETHINYL ESTRADIOL
Strength0.15MG,N/A;0.02MG,0.01MG
Dosage formTABLET
RouteORAL-28
ModalitySmall molecule
FDA approvalAugust 2015
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.